Submit your manuscript via our online submission system  
 
HKMJ is published bimonthly and indexed in MEDLINE/Index Medicus, Science Citation Index Expanded (SCIE), Current Contents–Clinical Medicine, BIOSIS Previews, Embase/Excerpta Medica, Biological Abstracts, Index Copernicus, and SCOPUS. The 2022 Journal Impact Factor for the HKMJ is 3.7 (Clarivate, 2023). The 2022 CiteScore for the HKMJ is 1.9 (Scopus, 2023).
 
  • https://www.hkmj.org/COVID-19
  • http://www.hkamedtrack.org/hkmj
April 2024, Vol. 30, No. 2
 

 

Highlights of this issue
Editorial
Informed consent: clarifying the post-Montgomery duty of care to discuss ‘reasonable alternative treatment’
Gilberto KK Leung
Hong Kong Med J 2024 Apr;30(2):88–9  |  Epub 28 Mar 2024
Editorial
Call to action: bridging gaps in lipid management in Hong Kong
Bryan PY Yan, Kui Kai Lau, Andrea OY Luk, Martin CS Wong
Hong Kong Med J 2024 Apr;30(2):90–3  |  Epub 10 Apr 2024
Original Article  CME
Impact of a novel pre-hospital stroke notification programme on acute stroke care key performance indicators in Hong Kong: a multicentre prospective cohort study with historical controls
KY Cheng, Ellen LM Yu, Tafu Yamamoto, Julie CL Kwong, YK Ho, HK Ngan, WH Lin, Jessica MT Lau, CH Cheung, Gordon PC Lee, LH Siu, Bun Sheng, Winnie WY Wong, WY Man, Cathy CC Cheung, CT Tse
Hong Kong Med J 2024 Apr;30(2):94–101  |  Epub 5 Apr 2024
Medical Practice  CME
Hong Kong consensus recommendations on the management of pancreatic ductal adenocarcinoma
Stephen L Chan, CL Chiang, Kenneth SH Chok, AS Lee, Raymond SY Tang, Fiona MY Lim, KF Lee, Anna YP Tai, Sarah WM Lee, Regina CL Lo, Anthony WH Chan, Francis PT Mok; Endorsed by the Hong Kong Society of Hepatobiliary and Pancreatic Surgery and the Hong Kong Cancer Therapy Society
Hong Kong Med J 2024 Apr;30(2):147–62  |  Epub 9 Apr 2024
Case Report
HN Yau, WC Lo, YP Yuen, MT Leung, KL Ng
Hong Kong Med J 2024;30:Epub 31 May 2024
Editorial
Ivan FN Hung, Ada WC Lin, Jane CK Chan, Tony NH Chan, Philip Eng, Angus HY Lo, Martin CS Wong, William KK Wong
Hong Kong Med J 2024;30:Epub 29 May 2024
Original Article
Brian YC Sung, Eric HM Tang, Laura Bedford, Carlos KH Wong, Emily TY Tse, Esther YT Yu, Bernard MY Cheung, Cindy LK Lam
Hong Kong Med J 2024;30:Epub 29 May 2024
Case Report
CW Kong, YY Li, Sandy LK Au, Anita SY Kan, Martin MC Chui, Brian HY Chung, YC Ho, William WK To
Hong Kong Med J 2024;30:Epub 29 May 2024
Original Article
Alison WL Wan, Kevin KH Chung, JB Li, Derwin KC Chan
Hong Kong Med J 2024;30:Epub 21 May 2024
See more >>
Most Accessed Articles

Letter to the Editor
CK Chan, Raymond SM Wong, Jones CM Chan, YK Chong, Jamie Au Yeung, TH Yung
Hong Kong Med J 2022 Oct;28(5):413-4
Supplement
The Osteoporosis Society of Hong Kong (OSHK)
Hong Kong Med J 2024;30(Suppl 2):S1-34
Review Article
HS Kan, PK Chan, KY Chiu, CH Yan, SS Yeung, YL Ng, KW Shiu, Tegan Ho
Hong Kong Med J 2019 Apr;25(2):127-33 | Epub 28 Mar 2019
Reminiscence: Artefacts from The Hong Kong Museum of Medical Sciences
YC Tsao
Hong Kong Med J 2018 Feb;24(1):90–1
CURRENT ISSUE, April 2024, Volume 30(2)
Editorials
Informed consent: clarifying the post-Montgomery duty of care to discuss 'reasonable alternative treatment'
Call to action: bridging gaps in lipid management in Hong Kong
Original Articles
Impact of a novel pre-hospital stroke notification programme on acute stroke care key performance indicators in Hong Kong: a multicentre prospective cohort study with historical controls
Stevens–Johnson syndrome and toxic epidermal necrolysis in Hong Kong
Detection of significant liver fibrosis in Chinese psoriasis patients receiving methotrexate: a comparison between transient elastography and liver histology
Exploration of clinical and ethical issues in an expanded newborn metabolic screening programme: a qualitative interview study of healthcare professionals in Hong Kong
Prediction of hospital mortality among critically ill patients in a single centre in Asia: comparison of artificial neural networks and logistic regression–based model
Comparison of clinical characteristics between ACOSOG Z0011–eligible cohort and sentinel lymph node–positive breast cancer patients in Hong Kong